Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 28, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000080.pdf 0001968202-24-000080.xls
Feb 26, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001000275-24-000007.pdf 0001000275-24-000007.xls
Feb 26, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-001381.pdf 0001950047-24-001381.xls
Feb 26, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000072.pdf 0001968202-24-000072.xls
Feb 26, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000073.pdf 0001968202-24-000073.xls
Feb 26, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000074.pdf 0001968202-24-000074.xls
Feb 26, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000151.pdf 0001969223-24-000151.xls
Feb 23, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-001328.pdf 0001950047-24-001328.xls
Feb 22, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-001267.pdf 0001950047-24-001267.xls
Feb 22, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000135.pdf 0001969223-24-000135.xls

Data provided by Kaleidoscope.

Investors & Media